News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Proteostasis Therapeutics, Inc. Announces Additions of Key Executives; Peter H. Reinhart Joins as CSO and Gregory P. Licholai is Appointed COO



3/25/2010 10:49:54 AM

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Proteostasis Therapeutics announced today the appointments of Peter H. Reinhart, Ph.D., as Chief Scientific Officer and Gregory P. Licholai as Chief Operating Officer. Dr. Reinhart replaces interim CSO, Walter Newman, Ph.D., of Healthcare Ventures, who will remain with the company as a consultant.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES